TGFBI and familial pancreatic carcinoma: Our current work consequently focused in generating a humanized anti-βig-h3 Ab for testing in a clinical setting, to confirm the promising immunological role of stromal extracellular matrix protein βig-h3 in pancreatic cancer [16,17].